Zygmont Chester Stanley III has filed 4 insider transactions across 1 company since February 2025.
Most recent transaction: a tax payment of 13100 shares of REVELATION BIOSCIENCES, INC. ($REVB) on February 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | REVELATION BIOSCIENCES, INC. | $REVB | Zygmont Chester Stanley III | Chief Financial Officer | F | Common Stock | 13100 | $1.65 | 105,350.0000 | 5,924,137 | 11.06% | 0.22% |
| Jan. 8, 2026 | REVELATION BIOSCIENCES, INC. | $REVB | Zygmont Chester Stanley III | Chief Financial Officer | A | Common Stock | 78145 | $0.90 | 869,435.0000 | 5,924,137 | 9.88% | 1.32% |
| Oct. 29, 2025 | REVELATION BIOSCIENCES, INC. | $REVB | Zygmont Chester Stanley III | Chief Financial Officer | A | Common Stock | 390614 | $1.28 | 400,676.0000 | 905,228 | 3882.07% | 43.15% |
| Feb. 11, 2025 | REVELATION BIOSCIENCES, INC. | $REVB | Zygmont Chester Stanley III | Chief Financial Officer | A | Common Stock | 15048 | $3.87 | 15,117.0000 | 0 | 9999.99% | 0.00% |